Literature DB >> 17406431

Whole-body imaging with fluorescent proteins.

Robert M Hoffman1, Meng Yang.   

Abstract

The intrinsic brightness of fluorescent proteins has been taken advantage of to develop a technology of whole-body imaging of tumors and gene expression in mouse internal organs. Stable transformation with fluorescent protein genes can be effected using retroviral vectors containing a selectable marker such as neomycin resistance. The cells that stably express fluorescent proteins can then be transplanted into appropriate mouse models. For whole-body imaging, nude mice are very appropriate. If wild-type mice are used, then hair must be removed by shaving or depilation. The instruments used can range from a simple LED flashlight and appropriate excitation and emission filters to sophisticated equipment such as the Olympus OV100 with a wide range of magnification, enabling both macroimaging and microimaging. It is crucial that proper filters be used such that background autofluorescence is minimal. Fluorescent protein-based imaging technology can be used for whole-body imaging of fluorescent cells on essentially all organs. The timeline for these experiments varies from 2 days to 2 months.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406431     DOI: 10.1038/nprot.2006.223

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  92 in total

1.  Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected].

Authors:  Yingchun Wang; Jonathan A Kelber; Hop S Tran Cao; Greg T Cantin; Rui Lin; Wei Wang; Sharmeela Kaushal; Jeanne M Bristow; Thomas S Edgington; Robert M Hoffman; Michael Bouvet; John R Yates; Richard L Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

Review 3.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

4.  Real-time recording of circadian liver gene expression in freely moving mice reveals the phase-setting behavior of hepatocyte clocks.

Authors:  Camille Saini; André Liani; Thomas Curie; Pascal Gos; Florian Kreppel; Yann Emmenegger; Luigi Bonacina; Jean-Pierre Wolf; Yves-Alain Poget; Paul Franken; Ueli Schibler
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

5.  Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.

Authors:  Wei Hua; Chunjie Li; Zixiao Yang; Lihui Li; Yanan Jiang; Guangyang Yu; Wei Zhu; Zhengyan Liu; Shengzhong Duan; Yiwei Chu; Meng Yang; Yanmei Zhang; Ying Mao; Lijun Jia
Journal:  Neuro Oncol       Date:  2015-04-22       Impact factor: 12.300

Review 6.  Imaging enzymes at work: metabolic mapping by enzyme histochemistry.

Authors:  Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2010-02-01       Impact factor: 2.479

Review 7.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

Review 8.  New strategies for fluorescent probe design in medical diagnostic imaging.

Authors:  Hisataka Kobayashi; Mikako Ogawa; Raphael Alford; Peter L Choyke; Yasuteru Urano
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

9.  pcDNA3.1tdTomato is superior to pDsRed2-N1 for optical fluorescence imaging in the F344/AY-27 rat model of bladder cancer.

Authors:  Vincent Koo; Alvin Lee; Osama Sharaf Eldin; Chris Watson; Peter Hamilton; Kate Williamson
Journal:  Mol Imaging Biol       Date:  2009-12-15       Impact factor: 3.488

10.  Methodologies for the establishment of an orthotopic transplantation model of ovarian cancer in mice.

Authors:  Cunjian Yi; Lei Zhang; Fayun Zhang; Li Li; Shengrong Ling; Xiaowen Wang; Xiangqiong Liu; Wei Liang
Journal:  Front Med       Date:  2014-01-25       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.